146 related articles for article (PubMed ID: 14638468)
21. Pharmacodynamics of a novel des-F(6)-quinolone, BMS-284756, against Streptococcus pneumoniae in the thigh infection model.
Nicolau DP; Mattoes HM; Banevicius M; Xuan D; Nightingale CH
Antimicrob Agents Chemother; 2003 May; 47(5):1630-5. PubMed ID: 12709332
[TBL] [Abstract][Full Text] [Related]
22. A comparative clinical study of pneumonia by penicillin-resistant and -sensitive Streptococcus pneumoniae in a community hospital.
Watanabe H; Sato S; Kawakami K; Watanabe K; Oishi K; Rikitomi N; Ii T; Ikeda H; Sato A; Nagatake T
Respirology; 2000 Mar; 5(1):59-64. PubMed ID: 10728733
[TBL] [Abstract][Full Text] [Related]
23. Efficacy of trovafloxacin against penicillin-susceptible and multiresistant strains of Streptococcus pneumoniae in a mouse pneumonia model.
Bédos JP; Rieux V; Bauchet J; Muffat-Joly M; Carbon C; Azoulay-Dupuis E
Antimicrob Agents Chemother; 1998 Apr; 42(4):862-7. PubMed ID: 9559797
[TBL] [Abstract][Full Text] [Related]
24. Activities of garenoxacin against quinolone-resistant Streptococcus pneumoniae strains in vitro and in a mouse pneumonia model.
Azoulay-Dupuis E; Bédos JP; Mohler J; Peytavin G; Isturiz R; Moine P; Rieux V; Cherbuliez C; Péchère JC; Fantin B; Köhler T
Antimicrob Agents Chemother; 2004 Mar; 48(3):765-73. PubMed ID: 14982762
[TBL] [Abstract][Full Text] [Related]
25. Activity of the new quinolone WCK 771 against pneumococci.
Appelbaum PC; Pankuch GA; Bozdogan B; Lin G; Jacobs MR; Patel MV; Gupte SV; Jafri MA; De Souza NJ; Khorakiwala HF
Clin Microbiol Infect; 2005 Jan; 11(1):9-14. PubMed ID: 15649298
[TBL] [Abstract][Full Text] [Related]
26. Anti-pneumococcal activity of gatifloxacin compared with other quinolone and non-quinolone agents.
Hoellman DB; Lin G; Jacobs MR; Appelbaum PC
J Antimicrob Chemother; 1999 May; 43(5):645-9. PubMed ID: 10382885
[TBL] [Abstract][Full Text] [Related]
27. In vitro and in vivo antibacterial activities of AM-1155, a new 6-fluoro-8-methoxy quinolone.
Hosaka M; Yasue T; Fukuda H; Tomizawa H; Aoyama H; Hirai K
Antimicrob Agents Chemother; 1992 Oct; 36(10):2108-17. PubMed ID: 1332587
[TBL] [Abstract][Full Text] [Related]
28. Activity of gatifloxacin against strains resistant to ofloxacin and ciprofloxacin and its ability to select for less susceptible bacterial variants.
Fung-Tomc J; Gradelski E; Huczko E; Minassian B; Bonner DP
Int J Antimicrob Agents; 2001 Jul; 18(1):77-80. PubMed ID: 11463531
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of gatifloxacin alone and in combination with cefepime against penicillin-resistant Streptococcus pneumoniae in a rabbit meningitis model and in vitro.
Perrig M; Acosta F; Cottagnoud M; Gerber CM; Täuber MG; Cottagnoud P
J Antimicrob Chemother; 2001 May; 47(5):701-4. PubMed ID: 11328789
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and pharmacodynamics of gemifloxacin versus levofloxacin in guinea pig pneumococcal pneumonia induced by strains with decreased ciprofloxacin susceptibility.
García-Olmos M; Parra A; García-Calvo G; Ponte C; Giménez MJ; Aguilar L; Soriano F
Int J Antimicrob Agents; 2003 Jun; 21(6):568-73. PubMed ID: 12791471
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and efficacy of linezolid in a gerbil model of Streptococcus pneumoniae-induced acute otitis media.
Humphrey WR; Shattuck MH; Zielinski RJ; Kuo MS; Biermacher JJ; Smith DP; Jensen JL; Schaadt RD; Zurenko GE; Richards IM
Antimicrob Agents Chemother; 2003 Apr; 47(4):1355-63. PubMed ID: 12654670
[TBL] [Abstract][Full Text] [Related]
32. Antipneumococcal activity of DK-507k, a new quinolone, compared with the activities of 10 other agents.
Browne FA; Bozdogan B; Clark C; Kelly LM; Ednie L; Kosowska K; Dewasse B; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 2003 Dec; 47(12):3815-24. PubMed ID: 14638489
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of quinolones against secondary pneumococcal pneumonia after influenza virus infection in mice.
Hayashi K; Kadowaki SE; Takei M; Fukuda H
Antimicrob Agents Chemother; 2006 Feb; 50(2):748-51. PubMed ID: 16436736
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of a novel tetracycline derivative, glycylcycline, against penicillin-resistant Streptococcus pneumoniae in a mouse model of pneumonia.
Murakami K; Tateda K; Matsumoto T; Miyazaki S; Yamaguchi K
J Antimicrob Chemother; 2000 Oct; 46(4):629-32. PubMed ID: 11020264
[TBL] [Abstract][Full Text] [Related]
35. [Resistance study of community respiratory pathogens isolated in China from 2005 to 2007].
Sun HL; Yang QW; Xu YC; Wang H; Xie XL; Chen MJ; Zhang XZ; Liu Y; Ye HF; Sun ZY; Duan Q; Ni YX; Yu YS; Zhao WS; He L; Wang J; Ji P; Liu PP; Zhang LX
Zhonghua Yi Xue Za Zhi; 2009 Nov; 89(42):2983-7. PubMed ID: 20137709
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and pharmacodynamics of simulated human-like treatment with levofloxacin on experimental pneumonia induced with penicillin-resistant pneumococci with various susceptibilities to fluoroquinolones.
Croisier D; Chavanet P; Lequeu C; Ahanou A; Nierlich A; Neuwirth C; Piroth L; Duong M; Buisson M; Portier H
J Antimicrob Chemother; 2002 Sep; 50(3):349-60. PubMed ID: 12205059
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of survival and pharmacodynamic relationships for five fluoroquinolones in a neutropenic murine model of pneumococcal lung infection.
Ernst EJ; Klepser ME; Petzold CR; Doern GV
Pharmacotherapy; 2002 Apr; 22(4):463-70. PubMed ID: 11939681
[TBL] [Abstract][Full Text] [Related]
38. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand.
Reechaipichitkul W; Assawasanti K; Chaimanee P
Southeast Asian J Trop Med Public Health; 2006 Mar; 37(2):320-6. PubMed ID: 17124993
[TBL] [Abstract][Full Text] [Related]
39. Activity of non-fluorinated quinolones (NFQs) against quinolone-resistant Escherichia coli and Streptococcus pneumoniae.
Roychoudhury S; Twinem TL; Makin KM; McIntosh EJ; Ledoussal B; Catrenich CE
J Antimicrob Chemother; 2001 Jul; 48(1):29-36. PubMed ID: 11418510
[TBL] [Abstract][Full Text] [Related]
40. Pharmacodynamic activity of fluoroquinolones against ciprofloxacin-resistant Streptococcus pneumoniae.
Zhanel GG; Roberts D; Waltky A; Laing N; Nichol K; Smith H; Noreddin A; Bellyou T; Hoban DJ
J Antimicrob Chemother; 2002 May; 49(5):807-12. PubMed ID: 12003975
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
